亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

湖北拓楚慷元醫藥有限公司  

精細化工,化工中間體

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:陳琳
  • 電話:027-86939098
  • 傳真:027-86939098
  • QQ:1990527136
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 依澤替米貝/依替米貝|醋酸洗泌泰|禁發 鹽酸特比萘芬
依澤替米貝/依替米貝|醋酸洗泌泰|禁發 鹽酸特比萘芬
單價 22.00 / 公斤對比
銷量 暫無
發貨 湖北武漢市付款后24小時內
庫存 900公斤起訂1公斤
品牌 拓楚
型號 163222-33-1
規格 原料藥
過期 長期有效
更新 2013-05-23 22:29
 
詳細信息

依澤替米貝/依替米貝|醋酸洗泌泰|禁發 鹽酸特比萘芬|米諾地爾|丙酸氯倍他索|禁發 鹽酸普萘洛爾

依澤替米貝英文名稱 Ezetimibe 

依澤替米貝中文別名 1-(4-氟苯基)-(3R)-[3-(4-氟苯基)-(3S)-羥基丙基]-(4S)-(4-羥基苯基)-2-依澤替米貝丙內酰胺;依替米貝;伊折麥布;依折麥布 

依澤替米貝CAS RN 163222-33-1 

依澤替米貝EINECS號  

依澤替米貝分 子 式 C24H21F2NO3 

依澤替米貝分 子 量 409.4252

 依澤替米貝,依澤替米貝原料藥,依澤替米貝制藥,依澤替米貝生產,依澤替米貝制造,依澤替米貝供應,依澤替米貝銷售,依澤替米貝供應商,依澤替米貝生產商,依澤替米貝制造商,依澤替米貝制藥廠,依澤替米貝制藥企業,依澤替米貝生產企業,依澤替米貝制造企業,依澤替米貝生產廠家,依澤替米貝廠家,依澤替米貝價格,依澤替米貝CAS,依澤替米貝用途,依澤替米貝作用,依澤替米貝效用,依澤替米貝功效,依澤替米貝療效,依澤替米貝藥效,依澤替米貝藥理,依澤替米貝適應癥,依澤替米貝國藥準字,依澤替米貝批準文號,依澤替米貝批文,依澤替米貝藥品批文,依澤替米貝醫藥批文,依澤替米貝藥品生產許可證

©2025 湖北拓楚慷元醫藥有限公司 版權所有   技術支持:化工網   訪問量:7685  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |